After 14 years at Lundbeck, Chief Financial Officer Anders Götzsche will depart the Danish pharmaceutical firm no later than May 2022. He is set to join another, as of yet undisclosed, unlisted Danish company.
Deborah Dunsire, CEO at Lundbeck, expects to be able to announce where Götzsche is headed soon. However, it is safe to say that it isn't to one of Lundbeck's competitors, she tells MedWatch.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.